Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease-Reference-Cited by-同舟云学术

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

Published:2009-10-07 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Caslake Robert¹,Macleod Angus²,Ives Natalie³,Stowe Rebecca³,Counsell Carl⁴

Affiliation:

1. University of Aberdeen; Medecine & Therapeutics; Polwarth Building Foresterhill Aberdeen UK AB25 2ZD

2. University of Aberdeen; Medicine and Therapeutics; Polwarth Building Foresthill Aberdeen UK AB25 2ZD

3. Robert Aitken Institute, University of Birmingham; Birmingham Clinical Trials Unit, School of Cancer Sciences; Edgbaston Birmingham UK B15 2TT

4. University of Aberdeen; Division of Applied Health Sciences; Polwarth Building Foresterhill Aberdeen UK AB25 2ZD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference30 articles.

1. Levodopa or dopamine agonists, or deprenyl as initial treatment for Parkinson's disease. A randomized multicenter study;Caraceni;Parkinsonism & Related Disorders,2001

2. Dopamine agonists and deprenyl in comparison to levodopa for initial treatment of Parkinson disease;Caraceni;Movement Disorders,1997

3. A multicenter Italian randomised study on early treatment of Parkinson disease: comparison of l-dopa, l-deprenyl and dopaminoagonists. Study design and short term results;The Italian Parkinson Study Group;Italian Journal of Neurological Sciences,1992

4. Bromocriptine or selegiline, or both, to delay the need of levodopa therapy in “de novo” Parkinson’s disease patients [Abstract];Castro-Caldas;Movement Disorders,1996

5. Castro-Caldas A Sampaio C Botelho MA Gouveia A and the PARJUPAR study group PARJUPAR study: Bromocriptine, selegiline or both to delay the need of levodopa therapy in "de novo" Parkinson's disease patients Personal communication

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parkinson's disease: Are gut microbes involved?;Brain and Behavior;2023-06-20

2. SIMULTANEOUS UV METHOD DEVELOPMENT FOR DETERMINATION OF ROTIGOTINE HYDROCHLORIDE AND RASAGILINE MESYLATE;INDIAN DRUGS;2023-05-28

3. Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis;European Journal of Neurology;2023-05-25

4. Optimizing levodopa therapy, when and how? Perspectives on the importance of delivery and the potential for an early combination approach;Expert Review of Neurotherapeutics;2023-01-02

5. Mortality of Parkinson’s disease in Italy from 1980 to 2015;Neurological Sciences;2022-01-30